financetom
Business
financetom
/
Business
/
Emergent BioSolutions Wins $17 Million Government Contract Modification to Supply Smallpox Medication
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Emergent BioSolutions Wins $17 Million Government Contract Modification to Supply Smallpox Medication
Sep 15, 2025 6:09 PM

09:02 AM EDT, 09/15/2025 (MT Newswires) -- Emergent BioSolutions ( EBS ) said Monday that it has secured a $17 million contract modification from a research center within the US Department of Health and Human Services, or HHS, to supply its Tembexa smallpox treatment.

The company said it received the contract modification from the Biomedical Advanced Research and Development Authority, part of the Administration for Strategic Preparedness and Response within the HHS.

Emergent said the latest contract modification is part of the company's existing 10-year contract.

Shares of the company were up 2.3% in recent Monday premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Fennec Pharmaceuticals Makes Three Appointments, Including Pierre Sayad as Chief Medical Officer
Fennec Pharmaceuticals Makes Three Appointments, Including Pierre Sayad as Chief Medical Officer
Nov 3, 2024
07:11 AM EDT, 10/28/2024 (MT Newswires) -- Fennec Pharmaceuticals ( FENC ) on Monday appointed Pierre Sayad as chief medical officer, Terry Evans as chief commercial officer and Christiana Cioffi as chief strategy officer. All three appointments are effective immediately. Dr. Pierre Sayad was most recently chief operating officer and interim chief medical officer at Zephyr Labz. Terry Evans was...
Delta Air Lines Reportedly Sues CrowdStrike Over Tech Outage
Delta Air Lines Reportedly Sues CrowdStrike Over Tech Outage
Nov 3, 2024
07:12 AM EDT, 10/28/2024 (MT Newswires) -- Delta Air Lines ( DAL ) has filed a lawsuit against CrowdStrike ( CRWD ) over the global outage in July that caused mass flight cancellations and cost the carrier $500 million, media outlets reported over the weekend. In a case filed at the Fulton County Superior Court, Delta alleged that CrowdStrike (...
Bank of Hawaii's Q3 Earnings, Revenue Decline
Bank of Hawaii's Q3 Earnings, Revenue Decline
Nov 3, 2024
07:08 AM EDT, 10/28/2024 (MT Newswires) -- Bank of Hawaii Corp ( BOH ) reported Q3 earnings Monday of $0.93 per diluted share, down from $1.17 a year earlier. Four analysts polled by Capital IQ expected $0.83. Revenue for the quarter ended Sept. 30, expressed as the sum of net interest income and total noninterest income, was $162.7 million, compared...
AstraZeneca's Fasenra Approved in EU for Rare Vasculitis
AstraZeneca's Fasenra Approved in EU for Rare Vasculitis
Nov 3, 2024
07:13 AM EDT, 10/28/2024 (MT Newswires) -- AstraZeneca ( AZN ) said on Monday that its drug Fasenra has been approved in the European Union as an additional treatment for adults with relapsing or refractory eosinophilic granulomatosis with polyangiitis, a serious immune-related condition. The company said the decision follows a positive opinion from the Committee for Medicinal Products for Human...
Copyright 2023-2026 - www.financetom.com All Rights Reserved